Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Unknown 2Recruiting 2Active not recruiting 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 38OTHER_GOV 3INDUSTRY 2NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 431Breast Neoplasms 300Neoplasms 297Colorectal Neoplasms 245Neoplasm Metastasis 193Ovarian Neoplasms 173Lung Neoplasms 151Prostatic Neoplasms 149Recurrence 147Pancreatic Neoplasms 143Multiple Myeloma 134Stomach Neoplasms 130Squamous Cell Carcinoma of Head and Neck 128Melanoma 123Endometrial Neoplasms 119Leukemia, Myeloid, Acute 114Advanced Solid Tumors 113Advanced Solid Tumor 111Triple Negative Breast Neoplasms 103Carcinoma, Hepatocellular 102Uterine Cervical Neoplasms 90Small Cell Lung Carcinoma 88Lymphoma, Non-Hodgkin 84Carcinoma, Renal Cell 72Lymphoma, Follicular 71Lymphoma 69Leukemia, Lymphocytic, Chronic, B-Cell 65Solid Tumor 64Lymphoma, Large B-Cell, Diffuse 64Esophageal Neoplasms 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × INDUSTRY × Cognitive Dysfunction × Clear all
NCT07563777 2026-05-04

100-Year Human Aging Study

Longevity Metrics, Inc.

Recruiting
10,000 enrolled

Frailty, Cardiovascular Diseases, Dementia, Musculoskeletal Diseases, Neoplasms, Metabolic Syndrome, Cognitive Dysfunction

NCT06745583 2026-04-09

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Elixiron Immunotherapeutics (Hong Kong) Ltd.

Phase 2 Recruiting
15 enrolled
Lymphoid

Neuroinflammatory Diseases, Alzheimer Disease, Lymphoma, Follicular, Neurodegenerative Diseases, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡